Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 3, 1999, Pages 175-178

  Marroni, M ^a   Fiorio, M ^a   Menichetti, F ^a   Maghini, M ^a   Lenti, M ^a   Cao, P ^a   Repetto, A ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; TEICOPLANIN;

ADULT; AGED; ANESTHESIA INDUCTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; URINARY TRACT INFECTION; VASCULAR SURGERY; WOUND INFECTION;

EID: 0032751091     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050253     Document Type: Article

References (15)

1. 1. Herbst A, Kamme C, Norgren L, Qvarfordt P, Ribbe E, Thorne J: Infection and antibiotic prophylaxis in reconstructive vascular surgery. European Journal of Vascular Surgery (1989) 3:303-307
2. 2. Szilagyi ED, Smith RF, Elliott JP, Vrandecic MP: Infection in arterial reconstruction with synthetic grafts. Annals of Surgery (1972) 176:231-234
3. 3. Durham JR, Malone JM, Bernhard VM: The impact of multiple operation on the importance of arterial wall cultures. Journal of Vascular Surgery (1987) 5:160-167
4. 4. Hasselgren PO, Ivarsson L, Risberg B, Seeman T: Effects of prophylactic antibiotics in vascular surgery. Annals of Surgery (1984) 200:86-92
5. 5. American Medical Association: Antimicrobial chemoprophylaxis for surgical patients. Drug Evaluations Annual (1994) 32:1317-1321
6. 6. Brogden RN, Peters DH: Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1994) 47:823-854
7. 7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections. American Journal of Infection Control (1988) 16:128-140
8. 8. Szilagyi DE: Management of complications after arterial reconstruction. Surgical Clinics of North America (1979) 59:659-668
9. 9. Salzmann G: Perioperative infection prophylaxis in vascular surgery - a randomised prospective study. Thoracic Cardiovascular Surgeon (1983) 31:239-242
10. 10. Risberg B, Drott C, Dalman P, Holm J, Ivarsson, Jivegård L, Kariström L, Odén A, Pedersen P, Rahm V, Smith L, Thornell E, Wellander E, Örtenwall P: Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: a randomised double-blind, prospective multicentre study. European Journal of Vascular and Endovascular Surgery (1995) 10:346-351
11. 11. Worning AM, Frimodt-Moller N, Ostri P, Nilsson T, Hojholdt K, Frimodt-Moller C: Antibiotic prophylaxis in vascular reconstructive surgery: a double-blind placebo controlled study. Journal of Antimicrobial Chemotherapy (1986) 17:105-113
12. 12. Edwards WH, Jr, Kaiser AB, Kernodle DS, Appleby TC, Edwards WH Sr, Martin RS, Mulherin JL, Wood CA: Cefuroxime versus cefazolin as prophylaxis in vascular surgery. Journal of Vascular Surgery (1992) 15:35-42
13. 13. Edwards WH, Jr, Kaiser AB, Tapper S, Edwards WH, Sr, Martin RS III, Mulherin JL, Jr, Jenkins J, Roach A: Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis cost-effectiveness and risk factors. Journal of Vascular Surgery (1993) 18:470-476
14. 14. Calligaro KD, Azurin DJ, Dougherty MJ, Dandora R, Bajgier SM, Simper S, Savarese RP, Raviola CA, DeLaurentis DA: Pulmonary risk factors of elective abdominal aortic surgery. Journal of Vascular Surgery (1993) 18:914-921
15. 15. Pittet D, Wenzel RP: Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Archives of Internal Medicine (1995) 155:1177-1184